Article Type: Generic

Canada’s high performance computing (HPC) collaboratory (C3.ca) has developed a comprehensive long range plan (LRP) to strengthen the country’s computing infrastructure and move Canada into the top 10 of HPC computing nations.

The federal government has proposed changes to regulations for the pharmaceutical regulatory environment and has launched a 75-day consultation period. The proposed changes are designed to address key concerns of both the so-called innovative and generic drug manufacturing industries.

Vancouver’s ID Biomedical Corp (IDB) has scored a spectacular home run with a long-term agreement to sell its Fluviral influenza vaccine — produced and commercialized in Canada — into the US market.

The Canada Foundation for Innovation has announced the first winners under its new Research Hospital Fund (RHF) competition, awarding $61 million for 12 projects at eight institutions that successfully made the case for additional research infrastructure not typically covered by other CFI funds.

Outlines Industry Canada budget requests

Industry minister David Emerson has moved to allay concerns about potential cuts to Canada’s basic research engine with reassurances that the two granting councils for which he has responsibility remain high priorities and can expect budget increases in the future.

By Debbie Lawes

Quebec and the rest of Canada risk losing aerospace jobs to other countries unless the federal government moves quickly on a national aerospace policy that includes more money for R&D, export sales and small- and medium-sized enterprises (SMEs), warns the Bloc Québecois.

The federal government intends to devote five cents towards S&T for every dollar it spends in FY04-5, with nearly two thirds going to R&D. Ottawa plans to spend $9.2 billion this year, an increase of 2% over the $9.

Vancouver’s ID Biomedical Corp (IDB) has scored a spectacular home run with a long-term agreement to sell its Fluviral influenza vaccine — produced and commercialized in Canada — into the US market.

Nearly three quarters of Canadians believe that more money should be spent to strengthen the nation’s science and research capacity, with most making a positive connection between science capacity and our standard of living and quality of life.

The revamped Ontario Centres of Excellence (OCE) program is preparing to leverage a new centralized structure to strengthen its role in commercializing knowledge and inventions as the province gets ready to unveil an ambitious new commercialization strategy.